Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

计划入组 50 人 · 首次发布于 2023 年 9 月 25 日

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension

计划入组 5 人 · 首次发布于 2023 年 7 月 18 日

Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure Patients With Pulmonary Hypertension Group 2 (PreVail-PH2 OUS Study)

计划入组 20 人 · 首次发布于 2024 年 7 月 11 日

Heme iron polypeptide

C213 Microneedle System

drug delivery system

GRADIENT DENERVATION TECHNOLOGIES

France

Ryder System

United States

GOSHEN HEALTH SYSTEM

United States

Gradient's Pulmonary Artery Denervation System Receives FDA Breakthrough Designation for Pulmonary Hypertension

Gradient Denervation Technologies Expands Pulmonary Hypertension Trial and Appoints Stanton Rowe to Board

CMS Initiates National Coverage Analysis for Medtronic's Renal Denervation System